After COVID, a Continued Push for Diversity in Clinical Trials - Stand Up To Cancer

News

After COVID, a Continued Push for Diversity in Clinical Trials

Lessons learned during the pandemic offer insight and a path toward more progress amid what experts say is a huge and complex challenge.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.